Canaccord Genuity Group Boosts Niagen Bioscience (NASDAQ:NAGE) Price Target to $16.00
Niagen Bioscience (NASDAQ:NAGE – Get Free Report) had its price objective raised by equities research analysts at Canaccord Genuity Group from $13.00 to $16.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 13.72% […]
Niagen Bioscience (NASDAQ:NAGE – Get Free Report) had its price objective raised by equities research analysts at Canaccord Genuity Group from $13.00 to $16.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 13.72% […]
